Skip to main content

Table 2 Virtual trial results summary for STAR-2D and STAR-3D

From: 3D kernel-density stochastic model for more personalized glycaemic control: development and in-silico validation

 

STAR-2D

STAR-3D

Number of patients

681

681

Hours of control (h)

59,073

59,071

Total BG measurements

31,248

31,858

Workload (measurements per day)

12.7

12.9

Median [IQR] BG (mmol/L)

6.3 [5.7 7.0]

6.2 [5.6 6.9]

% BG in 4.4–6.5 mmol/L

56

61

% BG in 4.4–7.0 mmol/L

72

75

% BG in 4.4–8.0 mmol/L

88

88

% BG in 8.0–10.0 mmol/L

8

7

% BG > 10.0 mmol/L

3

3

% BG < 4.4 mmol/L

2

2

% BG < 4.0 mmol/L

1

1

% BG < 2.2 mmol/L

0.03

0.03

# patients < 2.2 mmol/L

11 (1.6%)

11 (1.6%)

Median [IQR] insulin rate (U/h)

2.5 [1.5 4.5]

3.0 [1.5 5.0]

Median [IQR] dextrose rate (%GF)

95 [40 100]

97 [36 100]